Mutual Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $546K | Sell |
2,872
-34
| -1% | -$5.84K | 0.01% | 900 |
|
|
2026
Q1 | $491K | Sell |
2,906
-6,411
| -69% | -$1.1M | 0.01% | 889 |
|
|
2025
Q4 | $1.57M | Buy |
9,317
+3,008
| +48% | +$489K | 0.03% | 423 |
|
|
2025
Q3 | $975K | Sell |
6,309
-1,421
| -18% | -$194K | 0.02% | 580 |
|
|
2025
Q2 | $1.05M | Sell |
7,730
-1,359
| -15% | -$167K | 0.03% | 490 |
|
|
2025
Q1 | $1.12M | Sell |
9,089
-211
| -2% | -$28.6K | 0.03% | 418 |
|
|
2024
Q4 | $1.24M | Sell |
9,300
-300
| -3% | -$42.2K | 0.04% | 414 |
|
|
2024
Q3 | $1.36M | Sell |
9,600
-108
| -1% | -$15.6K | 0.04% | 379 |
|
|
2024
Q2 | $1.44M | Sell |
9,708
-1,100
| -10% | -$147K | 0.04% | 356 |
|
|
2024
Q1 | $1.48M | Buy |
10,808
+747
| +7% | +$102K | 0.05% | 343 |
|
|
2023
Q4 | $1.37M | Sell |
10,061
-1,626
| -14% | -$198K | 0.05% | 364 |
|
|
2023
Q3 | $1.43M | Sell |
11,687
-12,579
| -52% | -$1.6M | 0.06% | 330 |
|
|
2023
Q2 | $3.08M | Buy |
24,266
+1,702
| +8% | +$221K | 0.12% | 177 |
|
|
2023
Q1 | $2.91M | Sell |
22,564
-672
| -3% | -$88K | 0.12% | 174 |
|
|
2022
Q4 | $3.05M | Sell |
23,236
-379
| -2% | -$49K | 0.14% | 158 |
|
|
2022
Q3 | $2.76M | Buy |
23,615
+1,762
| +8% | +$219K | 0.14% | 145 |
|
|
2022
Q2 | $2.57M | Sell |
21,853
-1,920
| -8% | -$228K | 0.17% | 146 |
|
|
2022
Q1 | $3.1M | Buy |
23,773
+3,978
| +20% | +$518K | 0.17% | 134 |
|
|
2021
Q4 | $3.02M | Buy |
19,795
+251
| +1% | +$38.9K | 0.16% | 151 |
|
|
2021
Q3 | $3.16M | Buy |
19,544
+4,393
| +29% | +$739K | 0.19% | 131 |
|
|
2021
Q2 | $2.48M | Buy |
15,151
+2,183
| +17% | +$336K | 0.15% | 174 |
|
|
2021
Q1 | $1.95M | Sell |
12,968
-143
| -1% | -$22.7K | 0.13% | 187 |
|
|
2020
Q4 | $1.99M | Sell |
13,111
-171
| -1% | -$24.4K | 0.15% | 165 |
|
|
2020
Q3 | $1.8M | Buy |
13,282
+105
| +0.8% | +$14.2K | 0.16% | 154 |
|
|
2020
Q2 | $1.8M | Sell |
13,177
-368
| -3% | -$46.9K | 0.18% | 141 |
|
|
2020
Q1 | $1.46M | Buy |
13,545
+284
| +2% | +$32.7K | 0.2% | 138 |
|
|
2019
Q4 | $1.6M | Buy |
13,261
+650
| +5% | +$72.5K | 0.17% | 145 |
|
|
2019
Q3 | $1.25M | Buy |
12,611
+92
| +0.7% | +$9.63K | 0.17% | 151 |
|
|
2019
Q2 | $1.37M | Sell |
12,519
-9
| -0.1% | -$957 | 0.18% | 139 |
|
|
2019
Q1 | $1.4M | Buy |
12,528
+650
| +5% | +$71.3K | 0.21% | 117 |
|
|
2018
Q4 | $1.15M | Sell |
11,878
-104
| -0.9% | -$11K | 0.23% | 112 |
|
|
2018
Q3 | $1.46M | Buy |
11,982
+2,755
| +30% | +$324K | 0.22% | 111 |
|
|
2018
Q2 | $1.01M | Buy |
9,227
+48
| +0.5% | +$5.13K | 0.23% | 137 |
|
|
2018
Q1 | $980K | Buy |
9,179
+1,248
| +16% | +$138K | 0.25% | 134 |
|
|
2017
Q4 | $847K | Buy |
+7,931
| New | +$848K | 0.32% | 99 |
|
Other funds holding IBB
CB
Mutual Advisors's IBB Position: Q2 2026 in Review
Mutual Advisors reduced its iShares Biotechnology ETF (IBB) stake by 1.2% in Q2 2026, selling an estimated $5.84K and leaving 2,872 shares worth $546K. The position accounts for 0.01% of the portfolio, ranked #900.
Mutual Advisors first reported a position in IBB in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.16M in Q3 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Mutual Advisors held 2,872 shares of iShares Biotechnology ETF worth $546K as of Q2 2026.
- Mutual Advisors sold 34 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.84K.
- iShares Biotechnology ETF made up 0.01% of Mutual Advisors's portfolio in Q2 2026, its #900 holding.
- Mutual Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 35 quarters since.
- Mutual Advisors's iShares Biotechnology ETF position peaked at $3.16M in Q3 2021.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.